Roche first quarter sales beat expectations, helped by rising Tecentriq revenue

Swiss drugmaker Roche’s first-quarter revenue rose 4 percent, more than expected, as the biggest maker of oncology medicines said on Thursday it was lifted by not only its newer cancer drugs but also older drugs whose sales held their own.

Sourced through Scoop.it from: www.reuters.com

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s